Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Probe Faults Nu Skin Compliance, But No Challenge To Business Model

This article was originally published in The Tan Sheet

Executive Summary

Nu Skin says China’s review led to fines of $524,000 for representatives’ sales of products that “while permitted for sale in Nu Skin China’s retail stores, were not registered for the direct-selling channel,” and $16,000 “for product claims that were deemed to lack sufficient documentary support.”

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106826

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel